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Polycystic ovary syndrome (PCOS) is a multigenic
complex disorder causing metabolic and gynecologic
dysfunctions in women of reproductive age. Its cardinal
features include hyperandrogenemia, chronic anovula-
tion, insulin resistance and hyperinsulinemia. Women
with PCOS are at increased risk to develop long term
health implications like endometrial cancer, T2DM and
cardiovascular diseases. Insulin-like factor 3 (INSL3),
also known as relaxin-like factor (RLF), is a member of
the relaxin-like hormone family. Relaxin and INSL3 are
peptide hormones with a number of important physiolo-
gical roles in reproduction, regulation of extracellular
matrix turnover, and cardiovascular function. INSL3 is a
theca cell-secreted paracrine factor which regulates
androgen production and has been implicated a role in
follicle selection and resulting ovulation. In women, it is
produced in lower amounts by ovarian theca and luteal
cells, and circulating levels are increased in women with
polycystic ovarian syndrome. This suggests that INSL3
may have a modulatory role in ovarian function. The
INSL3 gene is localized on chromosome 19 and comprises
of two exons and an intron. Novel and known variations
in both exonic regions were investigated to understand
their influence in PCOS pathophysiology. Genotyping
of these polymorphisms were carried out by direct sequen-
cing in 150 women with PCOS and 150 normal menstru-
ating women. Clinical, biochemical and hormonal
parameters were also assessed in these women. Analysis
revealed association of db6523 SNP in exon 1 and
rs1003887 polymorphism of exon 2 with susceptibility to
PCOS. Other exonic region polymorphisms failed to show
any association with PCOS pathophysiology.
Authors’ details
1National Institute for Research in Reproductive Health, J.M. Street, Parel,
Mumbai- 400012, India. 2Department of Endocrinology, Seth GS Medical
College, Mumbai- 400012, India.
Published: 21 January 2014
doi:10.1186/1755-8166-7-S1-P93
Cite this article as: Shaikh et al.: Do variations in Insulin-like Factor 3
(INSL3) gene affect PCOS susceptibility? Molecular Cytogenetics 2014
7(Suppl 1):P93.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
1National Institute for Research in Reproductive Health, J.M. Street, Parel,
Mumbai- 400012, India
Full list of author information is available at the end of the article
Shaikh et al. Molecular Cytogenetics 2014, 7(Suppl 1):P93
http://www.molecularcytogenetics.org/content/7/S1/P93
© 2014 Shaikh et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
